“My hunch is we won’t see any progress on uplisting prior to an EUA.”

I agree. Like Cdiddy has said, uplisting is outside of the top 5 things that CYDY needs to focus on. Why? Because if CYDY completes #1, which is get leronlimab approved for COVID, uplisting will occur without effort. I have sacrificed leronlimab shares to the biotech gods with the hope that investors will stop asking about uplisting during CCs, but my sacrifices have yet to be answered.